pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,970 catalysts · 5,347 phase readout · 2,277 8k filing · 343 pdufa · 254 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,277
  • pdufa343
  • earnings254
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07540338: A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder

Sponsor: Alzamend Neuro, Inc.. Phase: PHASE1. Conditions: Bipolar I Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07534358: Intensive Case Management Between VA and Community Care for Suicide Prevention

Sponsor: VA Eastern Colorado Health Care System. Phase: NA. Conditions: Suicidal Ideation, Mental Health Issue, Social Determinants of Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT07621458: Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism

Sponsor: Seoul National University Hospital. Phase: . Conditions: Primary Aldosteronism

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06884748: Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy

Sponsor: Medical College of Wisconsin. Phase: EARLY_PHASE1. Conditions: Clostridioides Difficile Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07610148: A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy Participants

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07451548: RCT on Running Water Sound During Urodynamic

Sponsor: Princess Margaret Hospital, Hong Kong. Phase: NA. Conditions: Lower Urinary Tract Symptoms (LUTS)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06547255: Exparel Versus Bupivacaine in Post-operative Pain Control

Sponsor: Case Western Reserve University. Phase: PHASE4. Conditions: Liposomal Bupivacaine

full page →ctgov ↗
›RECRUITINGphase readoutNCT05849155: Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition

Sponsor: St. Jude Children's Research Hospital. Phase: . Conditions: Genetic Predisposition

full page →ctgov ↗
›RECRUITINGphase readoutNCT07586826: Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Sponsor: Peking University People's Hospital. Phase: PHASE2. Conditions: Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers, Ovarian Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cervical Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07572526: tDCS: Sleep to Mood in Depression (S2M-D)

Sponsor: NYU Langone Health. Phase: NA. Conditions: Major Depressive Disorder, MDD, Depression, Major Depressive Episode

full page →ctgov ↗
›COMPLETEDphase readoutNCT04358926: Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)

Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: COVID-19, Desaturation of Blood

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06724926: Concurrent Azeliragon With Craniospinal Irradiation

Sponsor: NYU Langone Health. Phase: PHASE1. Conditions: Solid Tumor, High-grade Glioma, Leptomeningeal Metastasis

full page →ctgov ↗
›TERMINATEDphase readoutNCT06197178: A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)

Sponsor: Peking University. Phase: PHASE1. Conditions: Advanced Gastrointestinal Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT07623278: Bacterial Profile Changes During Different Sodium Hypochlorite Irrigation Regimens and Calcium Hydroxide Medicament in Root Canal Treatment

Sponsor: Hasanuddin University. Phase: NA. Conditions: Chronic Apical Abscess, Root Canal Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT05799755: Myositis Interstitial Lung Disease Nintedanib Trial

Sponsor: Rohit Aggarwal, MD. Phase: PHASE4. Conditions: Myositis Associated Interstitial Lund Disease (MA-ILD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06120855: Study on Regulated Cannabis Sales in Pharmacies

Sponsor: University of Bern. Phase: NA. Conditions: Marijuana Smoking, Cannabis, Cannabis Use

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04276155: Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

Sponsor: Centre Hospitalier de PAU. Phase: PHASE4. Conditions: Atrial Fibrillation, Myocardial Infarction

full page →ctgov ↗
›WITHHELDphase readoutNCT05535426: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT04362826: Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer

Sponsor: Case Comprehensive Cancer Center. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07537985: Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment

Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Hepatocellulcar Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07442643: Epinephrine-Added Irrigation Versus Intravenous Tranexamic Acid in Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Trial

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Rotator Cuff Tear

full page →ctgov ↗
›COMPLETEDphase readoutNCT02696343: Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants

Sponsor: University of Nebraska Lincoln. Phase: NA. Conditions: Infant, Extremely Low Birth Weight, Feeding Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT07402915: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07181915: Changing Outcomes Through Achievement Emails in COPD Using Routine Healthcare Audits

Sponsor: University of Leeds. Phase: NA. Conditions: COPD (Chronic Obstructive Pulmonary Disease)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07122011: Neural Contributions to Exercise-Induced Hypoalgesia With Blood Flow Restriction

Sponsor: University of Gran Rosario. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT03372811: Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)

Sponsor: Psoriasis Research Institute of Guangzhou. Phase: PHASE2. Conditions: Psoriasis Vulgaris, Topical Administration

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05490771: Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07596771: Effects of AI-Generated Animated Videos on Dental Anxiety in Children

Sponsor: Alanya Alaaddin Keykubat University. Phase: NA. Conditions: Pediatric Dental Anxiety

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07426744: Antipyretic Therapy With and Without Cold Sponging

Sponsor: Muhammad Aamir Latif. Phase: NA. Conditions: Fever

full page →ctgov ↗
›COMPLETEDphase readoutNCT03915444: Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma

Sponsor: HonorHealth Research Institute. Phase: PHASE2. Conditions: Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06259734: Transfusion Camp for Medical Students in Rwanda

Sponsor: University of British Columbia. Phase: NA. Conditions: Global Health, Medical Education

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07518264: Efficacy and Underlying Mechanisms of Group-Based Natural Psychotherapy for Anxiety Disorder

Sponsor: Beijing HuiLongGuan Hospital. Phase: NA. Conditions: Obsessive - Compulsive Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06580509: TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study

Sponsor: The University of Texas Health Science Center at San Antonio. Phase: EARLY_PHASE1. Conditions: Hemorrhage, Surgical, Tonsillar Bleeding

full page →ctgov ↗
›RECRUITINGphase readoutNCT07503509: Physiological Study of High PEEP in Noninvasive Ventilation

Sponsor: Chongqing Medical University. Phase: NA. Conditions: Respiratory Failure With Hypoxia

full page →ctgov ↗
›SUSPENDEDphase readoutNCT04222309: Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Sponsor: Northwell Health. Phase: PHASE1. Conditions: Glioma, Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain, GBM, Brain Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05752799: Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids

Sponsor: G.Gennimatas General Hospital. Phase: NA. Conditions: Opioid Use, Unspecified, Bariatric Surgery Candidate

full page →ctgov ↗
›COMPLETEDphase readoutNCT05883332: A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters

Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Lower Urinary Tract Symptoms

full page →ctgov ↗
›COMPLETEDphase readoutNCT06704932: A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the Knee

Sponsor: Sanofi. Phase: PHASE1. Conditions: Osteoarthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05410132: Internet-based Mindfulness-based Training (iMBT) for People With Depression

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Mindfulness, Depression

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05792332: Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta. Phase: NA. Conditions: Atypical Parkinsonism, MSA - Multiple System Atrophy, PSP, Nurse-Patient Relations, Nurse Physician Relations

full page →ctgov ↗
›TERMINATEDphase readoutNCT05724498: Brief Versus Standard Cognitive Behavioral Therapy for Insomnia in Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Insomnia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07391098: Peripheral Perfusion and Outcomes in ICU Patients With Sepsis

Sponsor: Alexandra Elena Lazăr. Phase: . Conditions: SEPSIS, Septic Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT07064798: Cryocompression for CIPN

Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Chemotherapy-induced Peripheral Neuropathy, Taxane-Induced Peripheral Neuropathy, CIPN - Chemotherapy-Induced Peripheral Neuropathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02942290: A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Sponsor: AbbVie. Phase: PHASE1. Conditions: Myelodysplastic Syndromes (MDS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06864013: SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE2. Conditions: Locally Advanced Rectal Cancer (LARC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07395960: The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment

Sponsor: Fudan University. Phase: PHASE1. Conditions: Mild Cognitive Impairment, Overweight or Obesity, Elderly

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05675982: Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells

Sponsor: Centre Henri Becquerel. Phase: NA. Conditions: Diffuse Large B Cell Lymphoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06556082: Effect of PNF-Based Upper Extremity Strengthening With Core Stabilization on Fitness in Amputee Football Players

Sponsor: Uskudar University. Phase: NA. Conditions: Amputation, Lower Limb Amputation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06471920: Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Chronic Low-back Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07250724: C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Sponsor: Bactolife A/S. Phase: . Conditions: Clostridioides Difficile Infection Recurrence

full page →ctgov ↗
← prev
page 98 of 160
next →